OTCPK:GBGPF - Post by User
Comment by
StayInCashon Feb 03, 2018 3:18pm
134 Views
Post# 27497129
RE:RE:Valued of the ACB - CMED deal = $12.646 ACB =$42.99 per CMED
RE:RE:Valued of the ACB - CMED deal = $12.646 ACB =$42.99 per CMED
Yes, the question is where to put your $24 worth of shares, regardless the denomination. But let's use $2400 worth of shares to defocus on the share price. But absolutely, people should focus on the cash value and find the right stocks. Not the other way around. Switiching between stocks is very cheap and hassle free if done in a TFSA or RRPS account. Non-registered accounts incur tax liabilities or write-offs depending if you are "in the money" or "bagholding" as you mention.
The three big MJ stocks in this sector are APH, WEED and ACB.
If it wasn't for CMED, APH would be the clear winner. It leads in inventory going into legalization and is apparently the lead in my provinces. I'm still researching this.
With CMED at $650M cost, ACB has made a very smart move an will, in time, be rewarded for it. As with others, ACB is under the bears' paws with a now deflated market value of $3.85B market cap. And specific to CMED, the differentials between CMED and ACB makes CMED even more attractive.
I can just imagine regular investors who bought at the top of any of these marijuana stocks looking at a 50% haircut and wondering if 100% haircut is possible. And the answer to that is no, not short or medium term.
At best, everyone here that is not a trader should HOLD or stay in cash. Unless the macro economics and markets tank, this will be seen as one of the best buying opportunities.